This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Aetna, Humana, Other HMOs Slip on Web Site Glitches

Last 12-Month Return (%) -- Stocks with a red number declined by that percentage over the last 12 months. Stocks with a black number increased by that percentage.

Forecast One-Year Return -- Stocks with a red number are projected to decline by that percentage over the next 12 months. Stocks with a black number in the Table are projected to move higher by that percentage over the next 12 months.

Value Level: is the price at which to enter a GTC Limit Order to buy on weakness. The letters mean; W-Weekly, M-Monthly, Q-Quarterly, S-Semiannual and A- Annual.

Pivot: A level between a value level and risky level that should be a magnet during the time frame noted.

Risky Level: The price at which to enter a GTC Limit Order to sell on strength.

When you look at the performances of the seven health maintenance stocks between Oct. 2 and Oct. 22, keep in mind that the S&P 500 is 3.6% from its Oct. 2 close and its Oct. 22 close.

Aetna (AET - Get Report) ($63.79 vs. $64.76 on Oct. 2) -- Between July 8 and Oct. 2, this stock was up just 2.4% despite setting a multi-year high at $69.19 on Sept. 16. From Oct. 2 through Oct. 22, this stock slipped 1.5% lagging the 3.6% gain of the S&P 500. The nation's largest health benefits company still has a buy rating with a semiannual value level at $60.96, an annual pivot at $62.77 and quarterly and monthly risky levels at $65.82 and $70.72.

Centene (CNC - Get Report) ($65.92 vs. $64.30 on Oct. 2) -- Between July 8 and Oct. 2, this stock popped 18%, but between Oct. 2 and Oct 22, it tacked on just 2.5%, which lags the S&P gain of 3.6%. The provider of health care services to individuals set a multiyear high at $67.84 on Oct. 22. My monthly value level is $63.01 with a quarterly pivot at $65.01 and weekly risky level at $67.64. Centene reported quarterly results on Oct. 22 and beat EPS estimates by 5 cents, earning 88 cents a share.
2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AET $114.63 0.73%
CNC $63.62 -2.87%
HNT $67.19 3.67%
HUM $177.87 0.17%
UNH $132.07 -0.55%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs